N. Sieben

v-Raf Murine Sarcoma Viral Oncogene Mutation Status in Serous Borderline Ovarian Tumors and the Effect on Clinical Behavior

P. V. van Diest, J. Dorsman, D. Rockx, 2009, International Journal of Gynecologic Cancer.

Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumors

A. Zee, I. Bijsmans, M. van Engeland, 2011, Modern Pathology.

Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors.

Jaime Prat, Jan Oosting, G. Fleuren, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PCR artifacts in LOH and MSI analysis of microdissected tumor cells.

G. Fleuren, A. Cleton-Jansen, C. Cornelisse, 2000, Human pathology.

In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low‐grade serous tumours

A. Flanagan, T. Krausz, T. Diss, 2004, The Journal of pathology.

Visualization of regional gene expression biases by microarray data sorting.

A. Cleton-Jansen, T. van Wezel, J. Oosting, 2004, BioTechniques.

Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors.

G. Fleuren, S. le Cessie, A. Cleton-Jansen, 2003, The American journal of pathology.